MedWellAI Inc.

What they do

MedWellAI operates through subsidiaries formed in July 2024: MedWell USA, a B2B e-commerce platform distributing pharmaceutical products, particularly GLP medications for weight loss and diabetes management, with an AI-powered ordering system for healthcare providers; and MedWell Facilities, a facilities management company focused on real estate opportunities for the health and wellness industry. The company previously operated digital asset mining in Granbury, Texas, which was discontinued as of June 7, 2024, and an online sales business from Healthy Lifestyle USA LLC that management ceased pursuing during fiscal 2025 due to regulatory hurdles. It was incorporated in 2011 as Lightcollar, Inc., renamed Integrated Ventures, Inc. in 2017, and renamed MedWellAI, Inc. in June 2025.

Revenue drivers

• Product sales (MedWell USA) — Revenue from distributing pharmaceutical products, particularly GLP medications; $1,622,679 for the nine months ended March 31, 2026 and $0 in the prior-year period, and $596,176 for the three months ended March 31, 2026.
• Commissions — Commission revenue was $576,931 for fiscal 2025, but declined to $2,702 for the nine months ended March 31, 2026 versus $409,368 in the prior-year period, and was $0 for the three months ended March 31, 2026.
• Rental income (MedWell Facilities) — Rental income was $67,500 for the nine months ended March 31, 2026 and $22,500 for the three months ended March 31, 2026, with $0 in the prior-year periods.
• Online sales (discontinued pursuit) — Online sales, obtained through the Healthy Lifestyle acquisition, generated $17,837 in fiscal 2025 and $1,601 for the nine months ended March 31, 2026, but management decided to no longer pursue this business due to regulatory hurdles.

Recent performance

For the nine months ended March 31, 2026, product sales were $1,622,679, commissions were $2,702, rental income was $67,500, and online sales were $1,601. For the three months ended March 31, 2026, product sales were $596,176, commissions were $0, rental income was $22,500, and online sales were $0. Fiscal 2025 revenue was $594,768, with commissions of $576,931 and online sales of $17,837, while the company reported a net loss of $3.6 million and negative operating cash flow of $848,531. As of March 31, 2026, total assets were $321,787, total liabilities were $7.8 million, shareholder equity was negative $7.7 million, and cash was $130,028. During fiscal 2025, goodwill of $670,329 and intangible assets of $81,796 were fully impaired.

Strategy

The company is focused on AI-driven healthcare and wellness solutions, operating through MedWell USA's B2B e-commerce platform for GLP medications and MedWell Facilities' real estate opportunities for healthcare providers and wellness clinics. It acquired 51% of Healthy Lifestyle USA LLC in August 2024 for $350,000, but subsequently ceased the online sales business due to regulatory hurdles. In June 2025, it changed its name to MedWellAI, Inc., and effective August 1, 2025, it amended and restated the Certificate of Designation for its Series C Preferred Stock, consolidating the Series C and Series D Preferred Stock classes. The company historically funded operations from digital asset mining and convertible notes, but mining was discontinued and it has not incurred additional debt or issued securities for cash.

Risks

• Going concern and history of losses — The company has minimal revenue, a history of losses including a $3.6 million net loss in fiscal 2025, and negative operating cash flow, with shareholder equity of negative $7.7 million as of March 31, 2026.
• Customer concentration — One customer generated approximately 96% of revenue during the year ended June 30, 2025, so losing that customer would substantially reduce revenue.
• Regulatory hurdles — Management decided to no longer pursue the online sales business obtained through the Healthy Lifestyle acquisition due to regulatory hurdles, resulting in full impairment of $670,329 of goodwill and $81,796 of intangible assets.
• AI technology risks — The company's use of AI and emerging technologies could produce deficient outputs, expose it to regulatory and cybersecurity risks, or be outpaced by competitors.

Outlook

Management has not provided specific financial guidance, but the company continues to operate MedWell USA's B2B pharmaceutical distribution platform and MedWell Facilities' real estate initiatives. The discontinued digital asset mining operations and online sales business mean future results depend on the GLP medication distribution and facilities management segments. The company states it has not incurred additional debt or issued securities for cash, and it continues to generate negative operating cash flow.